ZA966027B - The use of sertraline to treat post myocardial infarction patients. - Google Patents
The use of sertraline to treat post myocardial infarction patients.Info
- Publication number
- ZA966027B ZA966027B ZA9606027A ZA966027A ZA966027B ZA 966027 B ZA966027 B ZA 966027B ZA 9606027 A ZA9606027 A ZA 9606027A ZA 966027 A ZA966027 A ZA 966027A ZA 966027 B ZA966027 B ZA 966027B
- Authority
- ZA
- South Africa
- Prior art keywords
- sertraline
- myocardial infarction
- post myocardial
- infarction patients
- treat post
- Prior art date
Links
- 208000010125 myocardial infarction Diseases 0.000 title abstract 2
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 2
- 229960002073 sertraline Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US143795P | 1995-07-17 | 1995-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA966027B true ZA966027B (en) | 1998-01-16 |
Family
ID=21696010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9606027A ZA966027B (en) | 1995-07-17 | 1996-07-16 | The use of sertraline to treat post myocardial infarction patients. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0768083B1 (fr) |
| JP (1) | JPH0930959A (fr) |
| KR (1) | KR970005283A (fr) |
| CN (1) | CN1147937A (fr) |
| AT (1) | ATE235237T1 (fr) |
| AU (1) | AU721967B2 (fr) |
| CA (1) | CA2181225C (fr) |
| DE (1) | DE69626916T2 (fr) |
| DK (1) | DK0768083T3 (fr) |
| ES (1) | ES2192217T3 (fr) |
| IL (1) | IL118833A (fr) |
| MY (1) | MY117638A (fr) |
| NZ (1) | NZ299006A (fr) |
| PT (1) | PT768083E (fr) |
| ZA (1) | ZA966027B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL133080A0 (en) | 1997-07-01 | 2001-03-19 | Pfizer | Sertraline salts and sustained-release dosage forms of sertraline |
| TR199903282T2 (xx) * | 1997-07-01 | 2000-08-21 | Pfizer Products Inc. | Sertralin'in jelatin ile kaps�llenmi� ��zelti dozaj �ekli. |
| GB9714841D0 (en) * | 1997-07-14 | 1997-09-17 | Smithkline Beecham Plc | Treatment method |
| UA72743C2 (en) * | 1998-10-13 | 2005-04-15 | Pfizer Prod Inc | Essentially nonaqueous liquid pharmaceutical concentrate composition containing sertraline, method of using this concentrate, method for treatment |
| US6727283B2 (en) * | 1998-10-13 | 2004-04-27 | Pfizer Inc. | Sertraline oral concentrate |
| US6245782B1 (en) | 1999-05-17 | 2001-06-12 | Heartdrug Research L.L.C. | Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors |
| GB0814466D0 (en) * | 2008-08-07 | 2008-09-10 | Rosemont Pharmaceuticals Ltd | Sertraline composition |
| WO2020231187A1 (fr) * | 2019-05-15 | 2020-11-19 | 연세대학교 산학협력단 | Composition pour prévenir ou traiter les maladies cardio-cérébro-vasculaires comprenant comme principe actif un activateur de l'autophagie |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
-
1996
- 1996-07-03 AT AT96304906T patent/ATE235237T1/de not_active IP Right Cessation
- 1996-07-03 DK DK96304906T patent/DK0768083T3/da active
- 1996-07-03 EP EP96304906A patent/EP0768083B1/fr not_active Expired - Lifetime
- 1996-07-03 ES ES96304906T patent/ES2192217T3/es not_active Expired - Lifetime
- 1996-07-03 PT PT96304906T patent/PT768083E/pt unknown
- 1996-07-03 DE DE69626916T patent/DE69626916T2/de not_active Expired - Fee Related
- 1996-07-11 IL IL11883396A patent/IL118833A/xx not_active IP Right Cessation
- 1996-07-12 JP JP8200995A patent/JPH0930959A/ja active Pending
- 1996-07-15 CN CN96110584A patent/CN1147937A/zh active Pending
- 1996-07-15 CA CA002181225A patent/CA2181225C/fr not_active Expired - Fee Related
- 1996-07-16 AU AU60534/96A patent/AU721967B2/en not_active Ceased
- 1996-07-16 NZ NZ299006A patent/NZ299006A/xx unknown
- 1996-07-16 MY MYPI96002925A patent/MY117638A/en unknown
- 1996-07-16 ZA ZA9606027A patent/ZA966027B/xx unknown
- 1996-07-16 KR KR1019960028767A patent/KR970005283A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE235237T1 (de) | 2003-04-15 |
| EP0768083A2 (fr) | 1997-04-16 |
| NZ299006A (en) | 2000-08-25 |
| PT768083E (pt) | 2003-08-29 |
| DE69626916T2 (de) | 2003-10-09 |
| AU6053496A (en) | 1997-01-23 |
| EP0768083B1 (fr) | 2003-03-26 |
| KR970005283A (ko) | 1997-02-19 |
| MY117638A (en) | 2004-07-31 |
| DK0768083T3 (da) | 2003-06-23 |
| EP0768083A3 (fr) | 1999-12-01 |
| CA2181225C (fr) | 1999-03-23 |
| IL118833A0 (en) | 1996-10-31 |
| CA2181225A1 (fr) | 1997-01-18 |
| AU721967B2 (en) | 2000-07-20 |
| CN1147937A (zh) | 1997-04-23 |
| IL118833A (en) | 2000-07-26 |
| JPH0930959A (ja) | 1997-02-04 |
| DE69626916D1 (de) | 2003-04-30 |
| ES2192217T3 (es) | 2003-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU609664B1 (en) | A method of treating premature ejaculation using sertraline | |
| EP0703785A4 (fr) | Procedes de traitement de maladies et de troubles musculaires | |
| MY106075A (en) | A method of treating anxiety-related disorders using sertraline. | |
| IL118833A0 (en) | The use of sertraline to treat post myocardial infarction patients | |
| CA2167257A1 (fr) | Utilisation de sertraline pour traiter les malades atteints de cancer | |
| AU617622B2 (en) | A method of treating chemical dependencies using sertraline | |
| NZ268110A (en) | Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage | |
| NZ303993A (en) | Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders | |
| UA29461C2 (uk) | Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу | |
| ZA924128B (en) | New combination preparations for treatment of Parkinson's disease. | |
| MX9602793A (es) | Uso de sertralina para tratar pacientes despues de un infarto de miocardio. | |
| NZ268914A (en) | Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease | |
| MX9701528A (es) | Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer. |